المؤلفون: Ying, Zhixiong, van Eenige, Robin, Ge, Xiaoke, van Marwijk, Christy, Lambooij, Joost M, Guigas, Bruno, Giera, Martin, de Boer, Jan Freark, Coskun, Tamer, Qu, Hongchang, Wang, Yanan, Boon, Mariëtte R, Rensen, Patrick C N, Kooijman, Sander

المصدر: Ying , Z , van Eenige , R , Ge , X , van Marwijk , C , Lambooij , J M , Guigas , B , Giera , M , de Boer , J F , Coskun , T , Qu , H , Wang , Y , Boon , M R , Rensen , P C N & Kooijman , S 2023 , ' Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice ' , EBioMedicine , vol. 93 , 104684 . https://doi.org/10.1016/j.ebiom.2023.104684

مصطلحات موضوعية: Humans, Mice, Male, Animals, Non-alcoholic Fatty Liver Disease/drug therapy, Diabetes Mellitus, Type 2, Apolipoprotein E3/metabolism, Obesity/complications, Glucose, Triglycerides/metabolism, Cholesterol, Inflammation, Cholesterol Ester Transfer Proteins

وصف الملف: application/pdf

الاتاحة: https://hdl.handle.net/11370/30a846a9-1bdb-4e13-9c9d-894072d11d77
https://research.rug.nl/en/publications/30a846a9-1bdb-4e13-9c9d-894072d11d77
https://doi.org/10.1016/j.ebiom.2023.104684
https://pure.rug.nl/ws/files/777968533/1-s2.0-S2352396423002499-main.pdf

المؤلفون: Zhou, Enchen, Ge, Xiaoke, Nakashima, Hiroyuki, Li, Rumei, van der Zande, Hendrik J. P., Liu, Cong, Li, Zhuang, Müller, Christoph, Bracher, Franz, Mohammed, Yassene, de Boer, Jan Freark, Kuipers, Folkert, Guigas, Bruno, Glass, Christopher K, Rensen, Patrick C N, Giera, Martin, Wang, Yanan

المصدر: Zhou , E , Ge , X , Nakashima , H , Li , R , van der Zande , H J P , Liu , C , Li , Z , Müller , C , Bracher , F , Mohammed , Y , de Boer , J F , Kuipers , F , Guigas , B , Glass , C K , Rensen , P C N , Giera , M & Wang , Y 2023 , ' Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation ' , EMBO Molecular Medicine , vol. 15 , ....

مصطلحات موضوعية: Mice, Humans, Animals, Non-alcoholic Fatty Liver Disease/drug therapy, Desmosterol/pharmacology, Liver, Inflammation/drug therapy, Oxidoreductases, Inbred C57BL, Nerve Tissue Proteins, Oxidoreductases Acting on CH-CH Group Donors/pharmacology

وصف الملف: application/pdf

الاتاحة: https://hdl.handle.net/11370/0022eb05-0e49-4765-9267-379d115e8620
https://research.rug.nl/en/publications/0022eb05-0e49-4765-9267-379d115e8620
https://doi.org/10.15252/emmm.202216845
https://pure.rug.nl/ws/files/744461306/EMBO_Mol_Med_-_2023_-_Zhou.pdf

المؤلفون: Kongmalai, Tanawan, Srinonprasert, Varalak, Anothaisintawee, Thunyarat, Kongmalai, Pinkawas, McKay, Gareth, Attia, John, Thakkinstian, Ammarin

المصدر: Kongmalai , T , Srinonprasert , V , Anothaisintawee , T , Kongmalai , P , McKay , G , Attia , J & Thakkinstian , A 2023 , ' New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials ' , Frontiers in Endocrinology , vol. 14 , 1182037 . https://doi.org/10.3389/fendo.2023.1182037

مصطلحات موضوعية: Humans, Non-alcoholic Fatty Liver Disease/drug therapy, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Network Meta-Analysis, Glucagon-Like Peptide-1 Receptor, Randomized Controlled Trials as Topic, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide 1/therapeutic use, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

وصف الملف: application/pdf

الاتاحة: https://pure.qub.ac.uk/en/publications/245d4a3c-40a4-45e2-b7c6-e4a83ed23343
https://doi.org/10.3389/fendo.2023.1182037
https://pureadmin.qub.ac.uk/ws/files/495863556/fendo_14_1182037.pdf

المؤلفون: Lukkunaprasit, Thitiya, Tansawet, Amarit, Boonmanunt, Suparee, Sobhonslidsuk, Abhasnee, McKay, Gareth J, Attia, John, Thakkinstian, Ammarin

المصدر: Lukkunaprasit , T , Tansawet , A , Boonmanunt , S , Sobhonslidsuk , A , McKay , G J , Attia , J & Thakkinstian , A 2023 , ' An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand ' , Scientific Reports , vol. 13 , 5824 . https://doi.org/10.1038/s41598-023-33023-3

مصطلحات موضوعية: Humans, Non-alcoholic Fatty Liver Disease/drug therapy, Curcumin/therapeutic use, Iran, Thailand, Liver Cirrhosis

وصف الملف: application/pdf

الاتاحة: https://pure.qub.ac.uk/en/publications/19ca6af5-8728-4875-ba15-9ec2ce9cc08f
https://doi.org/10.1038/s41598-023-33023-3
https://pureadmin.qub.ac.uk/ws/files/444687097/s41598_023_33023_3_1_.pdf

المؤلفون: Hendriks, Delilah, Brouwers, Jos F, Hamer, Karien, Geurts, Maarten H, Luciana, Léa, Massalini, Simone, López-Iglesias, Carmen, Peters, Peter J, Rodríguez-Colman, Maria J, Chuva de Sousa Lopes, Susana, Artegiani, Benedetta, Clevers, Hans

المصدر: Hendriks , D , Brouwers , J F , Hamer , K , Geurts , M H , Luciana , L , Massalini , S , López-Iglesias , C , Peters , P J , Rodríguez-Colman , M J , Chuva de Sousa Lopes , S , Artegiani , B & Clevers , H 2023 , ' Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis ' , Nature Biotechnology , vol. 41 , no. 11 , pp. 1567-1581 . https://doi.org/10.1038/s41587-023-01680-4

مصطلحات موضوعية: Humans, Non-alcoholic Fatty Liver Disease/drug therapy, Drug Evaluation, Preclinical, Hepatocytes/metabolism, Lipid Metabolism, Apolipoproteins B/metabolism, Liver/metabolism

الاتاحة: https://pure.knaw.nl/portal/en/publications/8c7d76a5-e06d-431f-905b-525d80883c77
https://doi.org/10.1038/s41587-023-01680-4
https://hdl.handle.net/20.500.11755/8c7d76a5-e06d-431f-905b-525d80883c77

المؤلفون: Nielsen, Malte Hasle, Gillum, Matthew P, Vrang, Niels, Jelsing, Jacob, Hansen, Henrik H., Feigh, Michael, Oró, Denise

المصدر: Nielsen , M H , Gillum , M P , Vrang , N , Jelsing , J , Hansen , H H , Feigh , M & Oró , D 2023 , ' Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis ' , American Journal of Physiology: Gastrointestinal and Liver Physiology , vol. 324 , no. 5 , pp. G378-G388 . https://doi.org/10.1152/ajpgi.00157.2022

مصطلحات موضوعية: Mice, Animals, Male, Humans, Non-alcoholic Fatty Liver Disease/drug therapy, Liver Cirrhosis/metabolism, Inbred C57BL, Liver/metabolism, Obesity/metabolism, Diet, Biopsy, Disease Models, Animal, High-Fat/adverse effects

وصف الملف: application/pdf

الاتاحة: https://curis.ku.dk/portal/da/publications/hepatoprotective-effects-of-the-longacting-fibroblast-growth-factor-21-analog-pf05231023-in-the-gan-dietinduced-obese-and-biopsyconfirmed-mouse-model-of-nonalcoholic-steatohepatitis(358f35fe-e15a-4fa7-aede-fbe961e6d79b).html
https://doi.org/10.1152/ajpgi.00157.2022
https://curis.ku.dk/ws/files/345603759/ajpgi.00157.2022.pdf

المؤلفون: Ding, Lingling, Oligschlaeger, Yvonne, Shiri-Sverdlov, Ronit, Houben, Tom

المساهمون: von Eckardstein, Arnold, Binder, Christoph J.

المصدر: Ding , L , Oligschlaeger , Y , Shiri-Sverdlov , R & Houben , T 2022 , Nonalcoholic Fatty Liver Disease . in A von Eckardstein & C J Binder (eds) , Prevention and Treatment of Atherosclerosis : Improving State-of-the-Art Management and Search for Novel Targets . vol. 270 , Springer , Handbook of Experimental Pharmacology , pp. 233-269 . https://doi.org/10.1007/164_2020_352

مصطلحات موضوعية: Humans, Metabolic Syndrome/epidemiology, Non-alcoholic Fatty Liver Disease/drug therapy

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/d766c83f-c266-4fde-ad88-86b7b5ce6b69
https://doi.org/10.1007/164_2020_352

المساهمون: Jaehyun Bae, Ji Young Lee, Eugene Shin, Minyoung Lee, Yong-Ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Lee, Byung Wan

مصطلحات موضوعية: Animals, Diet, High-Fat / adverse effects, Disease Models, Animal, Fructose / metabolism, Glucose / metabolism, Glycoside Hydrolase Inhibitors / pharmacology, Inositol / analogs & derivatives, Lipogenesis, Liver / metabolism, Male, Mice, Inbred C57BL, Non-alcoholic Fatty Liver Disease* / drug therapy, Non-alcoholic Fatty Liver Disease* / metabolism, Pioglitazone / metabolism, Pioglitazone / pharmacology

وصف الملف: application/pdf

Relation: SCIENTIFIC REPORTS; J02646; OAK-2022-07301; OAK-2022-07302; OAK-2022-07306; OAK-2022-07316; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191899; T202204585; SCIENTIFIC REPORTS, Vol.12(1) : 13595, 2022-08

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/191899
https://doi.org/10.1038/s41598-022-15550-7

المساهمون: Mohamed Abu-Farha, Yong-Ho Lee, Jehad Abubaker, Lee, Yong Ho

مصطلحات موضوعية: Diabetes Mellitus, Type 2, Humans, Non-alcoholic Fatty Liver Disease* / drug therapy, GLP1 agonist, NAFLD, SGLT2 (sodium-glucose cotransporter 2) inhibitor, liver fat, thiazolidinediones

Relation: FRONTIERS IN ENDOCRINOLOGY; J03412; OAK-2022-09240; https://ir.ymlib.yonsei.ac.kr/handle/22282913/192856; T202205960; FRONTIERS IN ENDOCRINOLOGY, Vol.13 : 1010485, 2022-09

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/192856
https://doi.org/10.3389/fendo.2022.1010485

المساهمون: Kyuyeon Cho, Seoyeon Park, Ai Koyanagi, Louis Jacob, Dong Keon Yon, Seung Won Lee, Min Seo Kim, Seung Up Kim, Beom Kyung Kim, Jae Il Shin, Lee Smith, Kim, Seung Up

مصطلحات موضوعية: Exercise, Humans, Life Style, Non-alcoholic Fatty Liver Disease* / drug therapy, Randomized Controlled Trials as Topic, meta-analysis, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, randomized controlled study

Relation: OBESITY REVIEWS; J02407; OAK-2022-07860; OAK-2022-07861; OAK-2022-07862; https://ir.ymlib.yonsei.ac.kr/handle/22282913/192082; T202203508; OBESITY REVIEWS, Vol.23(9) : e13464, 2022-09

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/192082
https://doi.org/10.1111/obr.13464
https://onlinelibrary.wiley.com/doi/10.1111/obr.13464

المساهمون: Soyeon Shim, Maddeboina Krishnaiah, Madhusudana Reddy Sankham, Inha Kim, Yoseob Lee, Irin Shin, A Reum Oh, Hwa Jeong Lee, Thi Ngoc Lan Vu, Jongmi Park, Sun Choi, Seojeong Park, Youngjoo Kwon, Sungsoon Fang, Dae-Kee Kim, Fang, Sungsoon

مصطلحات موضوعية: Acrylates, Animals, Bile Acids and Salts / metabolism, Esters, Intestines, Liver / metabolism, Mice, Non-alcoholic Fatty Liver Disease* / drug therapy, Non-alcoholic Fatty Liver Disease* / metabolism, Rats, Receptors, Cytoplasmic and Nuclear / metabolism

Relation: JOURNAL OF MEDICINAL CHEMISTRY; J01588; OAK-2022-06715; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191691; T202203282; JOURNAL OF MEDICINAL CHEMISTRY, Vol.65(14) : 9,974-10,000, 2022-07

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/191691
https://doi.org/10.1021/acs.jmedchem.2c00641
https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00641

المساهمون: Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim, Lee, Hye Won

مصطلحات موضوعية: Carcinoma, Hepatocellular, Chronic Disease, Hepatitis, Viral, Human, Humans, Liver Diseases* / drug therapy, Liver Neoplasms, Non-alcoholic Fatty Liver Disease* / drug therapy, Cirrhosis, Non-antidiabetic drugs, Nonalcoholic fatty liver disease, Treatment, Viral hepatitis

Relation: CLINICAL AND MOLECULAR HEPATOLOGY; J00557; OAK-2022-06493; OAK-2022-06494; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191614; T202204549; CLINICAL AND MOLECULAR HEPATOLOGY, Vol.28(3) : 425-472, 2022-07

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/191614
https://doi.org/10.3350/cmh.2022.0186

المساهمون: Yongin Cho, Hyungjin Rhee, Young-Eun Kim, Minyoung Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Jin-Young Choi, Yong-Ho Lee, Kang, Eun Seok

مصطلحات موضوعية: Diabetes Mellitus, Type 2, Elasticity Imaging Techniques, Ezetimibe / therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Non-alcoholic Fatty Liver Disease* / diagnostic imaging, Non-alcoholic Fatty Liver Disease* / drug therapy, Non-alcoholic Fatty Liver Disease* / pathology, Hepatic fibrosis, Hepatic steatosis, Niemann-Pick C1-like 1 inhibitor, Statins

وصف الملف: application/pdf

Relation: BMC MEDICINE; J00364; OAK-2022-01620; https://ir.ymlib.yonsei.ac.kr/handle/22282913/188760; T202201731; BMC MEDICINE, Vol.20(1) : 93, 2022-03

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/188760
https://doi.org/10.1186/s12916-022-02288-2

المساهمون: Yongin Cho, Yong-Ho Lee, Lee, Yong Ho

مصطلحات موضوعية: Humans, Hypoglycemic Agents / therapeutic use, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease* / drug therapy, Non-alcoholic Fatty Liver Disease* / pathology, Clinical trial, Non-alcoholic fatty liver disease, Review, Therapeutics

Relation: Endocrinology and Metabolism(대한내분비학회지); J00773; OAK-2022-01658; https://ir.ymlib.yonsei.ac.kr/handle/22282913/188773; T202201712; Endocrinology and Metabolism (대한내분비학회지), Vol.37(1) : 38-52, 2022-02

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/188773
https://doi.org/10.3803/EnM.2022.102

المساهمون: Eugene Han, Ji Hye Huh, Eun Y Lee, Ji C Bae, Sung W Chun, Sung H Yu, Soo H Kwak, Kyong S Park, Byung-Wan Lee, Lee, Byung Wan

مصطلحات موضوعية: Diabetes Mellitus, Type 2* / complications, Type 2* / drug therapy, Dipeptidyl-Peptidase IV Inhibitors* / adverse effects, Double-Blind Method, Humans, Liver, Non-alcoholic Fatty Liver Disease* / complications, Non-alcoholic Fatty Liver Disease* / drug therapy, Piperazines, dipeptidyl peptidase-4 inhibitor, evogliptin, magnetic resonance imaging-derived proton density fat fraction, non-alcoholic fatty liver disease, pioglitazone, type 2 diabetes

Relation: DIABETES OBESITY & METABOLISM; J00722; OAK-2022-01593; https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336; T202200885; DIABETES OBESITY & METABOLISM, Vol.24(4) : 752-756, 2022-04

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336
https://doi.org/10.1111/dom.14623
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14623

المؤلفون: Manka, Paul P., Kaya, Eda, Canbay, Ali, Syn, Wing-Kin

المصدر: http://lobid.org/resources/99370675664106441#!, 66(11):3676-3688.

مصطلحات موضوعية: Diabetes, Invited Review, Non-alcoholic Fatty Liver Disease/drug therapy [MeSH], Humans [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], NASH, Fibrosis, NAFLD

Relation: https://repository.publisso.de/resource/frl:6464899; https://doi.org/10.1007/s10620-021-07206-9; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510897/

الاتاحة: https://repository.publisso.de/resource/frl:6464899
https://doi.org/10.1007/s10620-021-07206-9
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510897/

المؤلفون: Gastaldelli, Amalia, Stefan, Norbert, Häring, Hans-Ulrich

المصدر: http://lobid.org/resources/99370676916506441#!, 64(7):1461-1479.

مصطلحات موضوعية: Hypoglycemic Agents/pharmacology [MeSH], Incretins/pharmacology [MeSH], Insulin resistance, Farnesoid X receptor agonists, Liver/metabolism [MeSH], Liver/drug effects [MeSH], Non-alcoholic Fatty Liver Disease/complications [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Receptors, Cytoplasmic and Nuclear/metabolism [MeSH], Non-alcoholic steatohepatitis, Hypoglycemic Agents/therapeutic use [MeSH], Pharmaceutical Preparations/classification [MeSH], Hepatokines, Incretins/therapeutic use [MeSH], Molecular Targeted Therapy/methods [MeSH], SGLT2 inhibitors, Incretins, Non-alcoholic Fatty Liver Disease/drug therapy [MeSH], Type 2/complications [MeSH], Humans [MeSH], Non-alcoholic Fatty Liver Disease/metabolism [MeSH], Animals [MeSH], Fibrosis, Lipid Metabolism/drug effects [MeSH], Non-alcoholic fatty liver disease, Blood Glucose/metabolism [MeSH], Insulin Resistance/physiology [MeSH], Review

Relation: https://repository.publisso.de/resource/frl:6451920; https://doi.org/10.1007/s00125-021-05442-2; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187191/

الاتاحة: https://repository.publisso.de/resource/frl:6451920
https://doi.org/10.1007/s00125-021-05442-2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187191/

المساهمون: Taekyeong Yoo, Sae Kyung Joo, Hyo Jung Kim, Hyun Young Kim, Hyungtai Sim, Jieun Lee, Hee-Hoon Kim, Sunhee Jung, Youngha Lee, Oveis Jamialahmadi, Stefano Romeo, Won-Il Jeong, Geum-Sook Hwang, Keon Wook Kang, Jae Woo Kim, Won Kim, Murim Choi

مصطلحات موضوعية: Adult, Aged, Antifibrotic Agents / pharmacology, Antifibrotic Agents / therapeutic use, Female, Genome-Wide Association Study / methods, Genome-Wide Association Study / statistics & numerical data, Humans, Liver / pathology, Male, Mass Screening / methods, Mass Screening / statistics & numerical data, Middle Aged, Non-alcoholic Fatty Liver Disease / drug therapy, Non-alcoholic Fatty Liver Disease / epidemiology, Non-alcoholic Fatty Liver Disease / genetics, Republic of Korea / epidemiology, Transaminases / pharmacology, Transaminases / therapeutic use, AGXT2, NAFLD, NASH, eQTL, genetic variants

Relation: JOURNAL OF HEPATOLOGY; J01441; OAK-2022-04882; OAK-2022-04883; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190779; https://www.sciencedirect.com/science/article/pii/S0168827821002464; T9992022188; JOURNAL OF HEPATOLOGY, Vol.75(3) : 514-523, 2021-09

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/190779
https://doi.org/10.1016/j.jhep.2021.04.011
https://www.sciencedirect.com/science/article/pii/S0168827821002464

المؤلفون: EU-PNAFLD Investigators, GOLD Consortium

المساهمون: Faculty of Medicine

مصطلحات موضوعية: Lifur, Þríglýseríð, ALSPAC, Diabetes, Fibrosis, MBOAT7, NAFLD, Triglyceride, Liver / pathology, Liver Cirrhosis / metabolism, Liver Cirrhosis / pathology, Membrane Proteins / genetics, Acyltransferases / genetics, Non-alcoholic Fatty Liver Disease / drug therapy, Non-alcoholic Fatty Liver Disease / genetics, Hepatology

وصف الملف: 20-30

Relation: Journal of Hepatology; 74(1); http://www.scopus.com/inward/record.url?scp=85095843742&partnerID=8YFLogxK; EU-PNAFLD Investigators & GOLD Consortium 2021 , ' rs641738C >T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD : A meta-analysis ' , Journal of Hepatology , vol. 74 , no. 1 , pp. 20-30 . https://doi.org/10.1016/j.jhep.2020.08.027; 63c60630-3c82-438c-91bd-67f2ab4b1efb; 85095843742; https://hdl.handle.net/20.500.11815/3209

الاتاحة: https://hdl.handle.net/20.500.11815/3209
https://doi.org/10.1016/j.jhep.2020.08.027

المؤلفون: Scheen, André

المصدر: Revue Médicale Suisse, 19 (838), 1498-1502 (2023-08-23)

مصطلحات موضوعية: Hypoglycemic Agents, Dipeptidyl-Peptidase IV Inhibitors, 839I73S42A (Liraglutide), Humans, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents/adverse effects, Non-alcoholic Fatty Liver Disease/drug therapy, Liraglutide/therapeutic use, Human health sciences, Endocrinology, metabolism & nutrition, Gastroenterology & hepatology, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Gastroentérologie & hépatologie, Pharmacie, pharmacologie & toxicologie

Relation: urn:issn:1660-9379

URL الوصول: https://orbi.uliege.be/handle/2268/306109